Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress

Archives of Dermatological Research

Volumn 304, Issue 9, 2012, Pages 699-706

  Baek, Jin Ok ^a   Byamba, Dashlkhumbe ^b   Wu, Wen Hao ^b   Kim, Tae Gyun ^b   Lee, Min Geol ^b  

^a Gachon University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Antioxidant; Imiquimod; Mouse model; Psoriasis; ROS; SOD

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; IMIQUIMOD; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; WESTERN BLOTTING;

AMINOQUINOLINES; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PEROXIDASE; PSORIASIS; REACTIVE OXYGEN SPECIES; SKIN; SUPEROXIDE DISMUTASE;

EID: 84871238485     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-012-1272-y     Document Type: Article

References (42)

1. Ardavin C (2003) Origin, precursors and differentiation of mouse dendritic cells. Nat Rev Immunol 3(7):582-590
2. Berking C, Takemoto R, Binder RL, Hartman SM, Ruiter DJ, Gallagher PM, Lessin SR, Herlyn M (2002) Photocarcinogenesis in human adult skin grafts. Carcinogenesis 23(1):181-187
3. Bhagavathula N, Nerusu KC, Fisher GJ, Liu G, Thakur AB, Gemmell L, Kumar S, Xu ZH, Hinton P, Tsurushita N, Landolfi NF, Voorhees JJ, Varani J (2005) Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice. Am J Pathol 166(4):1009-1016
4. Conrad C, Nestle FO (2006) Animal models of psoriasis and psoriatic arthritis: an update. Curr Rheumatol Rep 8(5):342-347
5. Danilenko DM (2008) Review paper: preclinical models of psoriasis. Vet Pathol 45(4):563-575
6. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O (2000) LL-37, the neutrophil granuleand epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192(7):1069-1074
7. Dogan P, Soyuer U, Tanrikulu G (1989) Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasis. Br J Dermatol 120(2):239-244
8. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL (2001) Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus. J Invest Dermatol 117(1):91-97
9. Gabr SA, Al-Ghadir AH (2012) Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Arch Dermatol Res 304(6):451-457
10. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T, Gilliet M (2009) Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206(9):1983-1994
11. Gerbaud P, Petzold L, Therond P, Anderson WB, Evain-Brion D, Raynaud F (2005) Differential regulation of Cu, Zn- and Mnsuperoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts. J Autoimmun 24(1):69-78
12. Gilliet M, Conrad C, Geiges M, Cozzio A, Thurlimann W, Burg G, Nestle FO, Dummer R (2004) Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 140(12): 1490-1495
13. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG (2000) NKT cells: facts, functions and fallacies. Immunol Today 21(11):573-583
14. Gudjonsson JE, Johnston A, Dyson M, Valdimarsson H, Elder JT (2007) Mouse models of psoriasis. J Invest Dermatol 127(6): 1292-1308
15. Kharaeva Z, Gostova E, De Luca C, Raskovic D, Korkina L (2009) Clinical and biochemical effects of coenzyme Q (10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition 25(3):295-302
16. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schroder JM, Liu YJ, Gilliet M (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449(7162):564-569
17. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445(7130):866-873
18. Miyachi Y, Niwa Y (1983) Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes. Arch Dermatol Res 275(1):23-26
19. Nagaoka I, Tamura H, Hirata M (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol 176(5):3044-3052
20. Nelson KC, Carlson JL, Newman ML, Sternberg P Jr, Jones DP, Kavanagh TJ, Diaz D, Cai J, Wu M (1999) Effect of dietary inducer dimethylfumarate on glutathione in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 40(9): 1927-1935
21. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202(1):135-143
22. Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155(1): 145-158
23. Nickoloff BJ, Xin H, Nestle FO, Qin JZ (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25(6):568-573
24. Nikolic-Kokic A, Stevic Z, Blagojevic D, Davidovic B, Jones DR, Spasic MB (2006) Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin Chem Lab Med 44(5):589-593
25. Palamara F, Meindl S, Holcmann M, Luhrs P, Stingl G, Sibilia M (2004) Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol 173(5):3051-3061
26. Patel U, Mark NM, Machler BC, Levine VJ (2011) Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism. Br J Dermatol 164(3):670-672
27. Popov I, Lewin G (1991) A deficient function of the antioxidative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypotheses 35(3):229-236
28. Portugal M, Barak V, Ginsburg I, Kohen R (2007) Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations. Biomed Pharmacother 61(7):412-422
29. Rajan N, Langtry JA (2006) Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermatol 31(1):140-141
30. Raynaud F, Evain-Brion D, Gerbaud P, Marciano D, Gorin I, Liapi C, Anderson WB (1997) Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Free Radic Biol Med 22(4):623-632
31. Schon MP, Schon M, Klotz KN (2006) The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 126(6):1338-1347
32. Shen T, Zhu QX, Yang S, Wu CH, Zhang HF, Zhou CF, Zhang XJ (2008) Trichloroethylene induced cutaneous irritation in BALB/c hairless mice: histopathological changes and oxidative damage. Toxicology 248(2-3):113-120
33. Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J, Xing X, Nair RP, Voorhees JJ, Elder JT, Wang XJ, Sano S, Prens EP, DiGiovanni J, Pittelkow MR, Ward NL, Gudjonsson JE (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PloS one 6(4):e18266
34. Therond P, Gerbaud P, Dimon S, Anderson WB, Evain-Broin D, Raynaud F (1996) Antioxidant enzymes in psoriatic fibroblasts and erythrocytes. J Invest Dermatol 106(6):1325-1328
35. Thiele JJ, Schroeter C, Hsieh SN, Podda M, Packer L (2001) The antioxidant network of the stratum corneum. Curr Probl Dermatol 29:26-42
36. Utas S, Kose K, Yazici C, Akdas A, Kelestimur F (2002) Antioxidant potential of propylthiouracil in patients with psoriasis. Clin Biochem 35(3):241-246
37. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182(9): 5836-5845
38. Vanizor Kural B, Orem A, Cimsit G, Yandi YE, Calapoglu M (2003) Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 328(1-2): 71-82
39. Wierinckx A, Breve J, Mercier D, Schultzberg M, Drukarch B, Van Dam AM (2005) Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol 166(1-2):132-143
40. Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd Savoy L, Terlecky SR (2008) Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 128(11):2606-2614
41. Zheng Y, Niyonsaba F, Ushio H, Nagaoka I, Ikeda S, Okumura K, Ogawa H (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br J Dermatol 157(6):1124-1131
42. Zhou Q, Mrowietz U, Rostami-Yazdi M (2009) Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 47(7): 891-905